Biomeditsina va amaliyot jurnali, 2022 №1
Maqola mavzusi
ASSESSMENT OF CARDIOVASCULAR RISKS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND SECONDARY OSTEOARTHROSIS (320-324)
Mualliflar
SHODIKULOVA Gulandom Zikriyayevna ERGASHOVA Madina Muxtorovna KURBANOVA Zuxra Palvanovna UMAROV Inoyatillo Jo`raqulovich
Muassasa
Samarkand State Medical Institute
Annotatsiya
The aim of the study is to assess the degree of cardiovascular risk in patients with rheumatoid arthritis and secondary osteoarthritis. The increased risk of cardiovascular diseases on the SCORE scale is associated with negative dynamics of ACCP, CRP, CRP, IL-6, and this is important to take into account in clinical practice, especially in patients with secondary osteoarthritis in RA. Most ACCP positive patients who have been found to have RF and high disease activity have the highest cardiovascular risk
Kalit so'zlar
cardiovascular disease, comorbidities, rheumatoid arthritis, osteoarthritis
Adabiyotlar
1. Oganov RG, Simanenkov VI, Bakulin IG, et al. Comorbidities in clinical practice. Algorithms for diagnostics and treatment. Cardiovascular Therapy and Prevention. 2019;18(1):5-66. 2. Golightly YM, Jordan JM, Nelson AE, et al. Contributions of symptomatic osteoarthritis and physical function to incident cardiovascular disease. BMC Musculoskelet Disord. 2018;19(1):393. doi:10.1186/s12891-018-2311-4. 2. Fernandes GS, Valdes AM. Cardiovascular disease and osteoarthritis: common pathways and patient outcomes. Eur J Clin Invest. 2015;45(4):405-14. doi:10.1111/eci.12413. 3. Kabalyk MA, Nevzorova VA, Dubov VS, et al. Molecular and cellular effects of intraarticular injection of betamethasone in experimental osteoarthritis. Genij Ortopedii. 2020;26(1):65-71. 4. Menon J, Mishra P. Health care resource use, health care expenditures and absenteeism costs associated with osteoarthritis in US healthcare system. Osteoarthr Cartil. 2018;26(4):480-4. doi:10.1016/j.joca.2017.12.007. 5. Francisco V, Ruiz-Fernández C, Pino J, et al. Adipokines: Linking metabolic syndrome, the immune system, and arthritic diseases. Biochem Pharmacol. 2019;165:196-206. doi:10.1016/j. bcp.2019.03.030. 6. Popov AA, Izmozherova NV, Oboskalova TA. A one-step study of multimorbid pathology in women with estrogen deficiency. Ural Medical Journal. 2020;6:69-76. 7. 8.Smith KB, Smith MS. Obesity Statistics. PrimCare. 2016;43 (1):121-35. doi:10.1016/j.pop.2015.10.001. 8. Courties A, Gualillo O, Berenbaum F, Sellam J. Metabolic stressinduced joint inflammation and osteoarthritis. Osteoarthritis Cartilage. 2015;23(11):1955-65. doi:10.1016/j.joca.2015.05.016.10. Belluzzi E, El Hadi H, Granzotto M, et al. Systemic and Local Adipose Tissue in Knee Osteoarthritis. J Cell Physiol. 2017;232(8):1971-8. doi:10.1002/jcp.25716. 9. Улугбек Сунатович Пулатов, Гуландом Зикрияевна Шодикулова. Ревматоид артритнинг патогенези, ташхиси, клиникаси ва даволашнинг замонавий жиҳатлари. Journal of Biomedicine and Practice 2020, Special issue, pp.116-127SI-2 | 2020http:// dx.doi.org/10.26739/2181-9300-2020-SI-2-22 10. Чичасова Н.В., Владимиров С.А., Иголкина Е.В., Имаметдинова Г.Р. Бремя ревматоидного артрита: медицинские и социальные проблемы. Научно-практическая рев-матология. 2019; 47(1): 4–10. 11. Зинчук И.Ю., Амирджанова В.Н. Социальное бремя ревматоидного артрита. Научно- практическая ревматология. 2014; 52(3): 331–335. 12. 52(3): 331–335 (In Russian).] 13. Авдеева А.С. Новиков А.А., Александрова Е.Н. и др. Связь уровней цитокинов с активностью заболевания, уровнем аутоантител и деструктивными изменениями суставов при раннем ревматоидном артрите. Научнопрактическая ревматология. 2015; 53(4): 385–390. 14. Shodikulova Gulandom Zikriyaevna, Pulatov Ulugbek Sunatovich. Peripheral Blood System Status of Rheumatoid Arthritis Patients Depending on Haptoglobin Polymorphism. American Journal of Medicine and Medical Sciences 2020, 10(5): 351-353. DOI: 10.5923/j.ajmms.20201005.15